Challenging the management of drug-resistant tuberculosis &ndash; Authors&#39; reply

Lange Christoph G.; Dheda Keertan U.J.; Chesov Dumitru; Mandalakas A. M.; Udwadia Zarir Farokh; Horsburgh Charles Robert

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

495

SM ISO690:2012

LANGE, Christoph G., DHEDA, Keertan U.J., CHESOV, Dumitru, MANDALAKAS, A. M., UDWADIA, Zarir Farokh, HORSBURGH, Charles Robert. Challenging the management of drug-resistant tuberculosis – Authors' reply. In: The Lancet, 2020, vol. 395, pp. 783-784. ISSN 0140-6736. DOI: https://doi.org/10.1016/S0140-6736(20)30055-6

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

The Lancet

Volumul 395 / 2020 / ISSN 0140-6736

Challenging the management of drug-resistant tuberculosis – Authors' reply

DOI:https://doi.org/10.1016/S0140-6736(20)30055-6

Pag. 783-784

Lange Christoph G.¹, Dheda Keertan U.J.²³, Chesov Dumitru¹⁴, Mandalakas A. M.⁵, Udwadia Zarir Farokh⁶, Horsburgh Charles Robert⁷

¹ Research Center Borstel,
² University of Cape Town, Cape Town,
³ London School of Hygiene and Tropical Medicine,
⁴ ”Nicolae Testemițanu” State University of Medicine and Pharmacy,
⁵ Baylor College of Medicine,
⁶ Hinduja Hospital and Research Centre, Mumbai,
⁷ Boston University School of Medicine

Disponibil în IBN: 9 octombrie 2020

Cuvinte-cheie
isoniazid, quinoline derived antiinfective agent, rifamycin, tuberculostatic agent